Pharma

Pharma, Biotech VC Investments Continue Shift to Early Stage Deals

13 days ago   |   By Xconomy

The number of investments that venture capitalists will make this year in pharmaceutical and biotech companies is on pace to match last year's record-and that money continues to shift into earlier-stage deals. Venture firms invested in 609 drug development deals as of Sept. 30, 2019, compared with 808 deals for all last year, according to the latest data from firms that track VC investments. Since 2016, more than half of the money invested in pharma and biotech each year has been in the riskier angel, seed, Series A, and Series B stages, according to the latest Venture Monitor, a quarterly...
Read more ...

 


Search by Tags

   Pharma      Pharmaceutical      Biotech      BioTech      Drugs      Pharmaceuticals      Drug      National      National blog main      National top stories      Life Sciences      National Venture Capital Assocation      PitchBook      Startups      Venture Capital  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

SeaGen to Seek FDA Nod After Breast Cancer Drug Hits Goals of Key Study

SeaGen to Seek FDA Nod After Breast Cancer Drug Hits Goals of Key Study

An experimental breast cancer drug from Seattle Genetics is headed for FDA review after the company reported a pivotal clinical trial met its main goals. The company has been... Read more ...

Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer

Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer

Cancer therapies that harness the immune system don't work for all patients. Verseau Therapeutics aims to bring cancer immunotherapy to more people by targeting a type of... Read more ...

The secret of classic Belgian beers? Medieval super-yeasts

An international team of scientists led by Prof. Kevin Verstrepen and Prof. Steven Maere has discovered that some of the most renowned classic Belgian beers, including Gueuze... Read more ...

Edible grasshoppers can be modified for better fatty acid composition

It is possible to modify the fatty acid composition of edible grasshoppers by adding essential fatty acids in their feed, new research from the University of Eastern Finland... Read more ...

Manager, Engineering - Bachem - Vista, CA

The company provides a full range of services to the pharma and biotech industries. Handle complete project life cycle from design, planning and implementation...From Bachem... Read more ...

Bayer backs off running Casebia JV, as CRISPR Tx takes over management

Three years after Bayer and gene-editing biotech CRISPR Therapeutics joined forces to launch and run Casebia Therapeutics, the German Pharma is now handing over the full reins... Read more ...

Uncovering the principles behind RNA folding

Using high-throughput next-generation sequencing technology, a researcher found similarities in the folding tendencies among a family of RNA molecules called riboswitches... Read more ...

Listening in to how proteins talk and learning their language

A research team has created a third approach to engineering proteins that uses deep learning to distill the fundamental features of proteins directly from their amino acid... Read more ...

Pinpointing biomolecules with nanometer accuracy

Scientists demonstrate a new approach in fluorescence microscopy that can be used to locate individual biomolecules in 3D space with nanometer-scale precision. Read more ...

How the mouse X and Y chromosomes compete with each other to control offspring

New research presents the first demonstration of a specific difference in sperm function associated with sex ratio skewing. Read more ...